适体
生物相容性
膀胱癌
化学
靶向给药
药物输送
癌症治疗
靶向治疗
配体(生物化学)
药品
药理学
癌症研究
癌症
毒品携带者
纳米技术
生物活性
抗体
人血清白蛋白
组合化学
癌细胞
串联
生物物理学
医学
计算生物学
生物医学工程
作者
Wei Yao,Wencheng Shen,Huayuan Zhou,Xinfeng Dai,Dali Wei,Fei Zhao,Zhou Fang,Jiayi Wang,Xia Liu,Weihong Tan,Yu Pu Yang
出处
期刊:Small
[Wiley]
日期:2026-03-19
卷期号:22 (27): e14393-e14393
被引量:1
标识
DOI:10.1002/smll.202514393
摘要
Albumin‐based therapeutics are widely used in cancer treatment for their biocompatibility and hydrophobic drug‐loading capacity, but their efficacy is often limited by poor target specificity and weak binding affinity. Inspired by the multivalent and cooperative binding of immunoglobulin M (IgM), we developed a biomimetic tandem Y‐shaped Sgc8 aptamer‐albumin delivery system (TYS‐HSA). By grafting two hydrophilic aptamers onto each hydrophobic C18 side chain of poly(maleic anhydride‐alt‐1‐octadecene) (C 18 PMH), we constructed well‐defined multivalent aptamer units that self‐assembled with human serum albumin (HSA) into an IgM‐like ligand corona. Quantitative analysis revealed a high ligand valency of approximately 240 aptamers per TYS‐HSA nanoparticle, which, combined with its tandem Y‐shaped topology, enables cooperative multivalent recognition. This design achieved high‐affinity, stable target recognition while maintaining strong loading capacity for hydrophobic drugs such as paclitaxel. Compared with lower‐valency conjugates (MS‐HSA, approximately 95 aptamers per nanoparticle), TYS‐HSA showed enhanced target binding, prolonged cellular retention, and potent antitumor efficacy after a single intravesical administration in an orthotopic bladder cancer model. With broad drug compatibility and excellent physiological stability, this platform offers a promising and generalizable strategy for the targeted design of albumin‐based nanomedicines.
科研通智能强力驱动
Strongly Powered by AbleSci AI